Diphenoxylate Completed Phase 3 Trials for Lymphoma Diagnostic
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Diagnostic | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00583323 | Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET |
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Completed | Diagnostic | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT00583323 | Diphenoxylate / Atropine to Decrease FDG Activity During F-18 FDG PET |